United StatesDescription
App for assessing the efficacy and safety of SAR442970 in moderate to severe HS.
Your app for the HS OBTAIN study with Sanofi assessing the efficacy and safety of an anti-TNF-OX40L NANOBODY molecule, SAR442970 in participants with moderate to severe hidradenitis suppurativa.
Category Ranking
Review Breakdown
Screenshots
Download & Revenue
About
Bundle Id
com.thread.t7c806f7Min Os. Version
6.0Release Date
Mon, Oct 2, 2023Update Date
Mon, Mar 4, 2024Content Rating
EveryoneWhat's New
version
1709540062000updated
2 months agoInitial release.
Newsletter
Subscribe our newsletter and get useful information every week.
Publisher's Other Apps
Other Medical Apps
Similar Apps
Stay Ahead of the Market with StoreSpy
Start NowNever miss opportunities
Watch your competitors closely
Start boosting your app right away